CUBE
UKEntry
2024
Hold
2yr
Status
Active
Who owns CUBE?
CUBE is a British Biotech company, currently owned by Hg since 2024 and ARCHIMED. It changed hands in 2024, when Bregal Milestone sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Ownership history
3 ownership periods · co-invest detected
Co-invest · 3 holders · 2021 · present
ARCHIMEDActive
2021 · present(5yr) · MED III · 2021 · Buyout
Bregal MilestoneExited 2024
2022 · 2024(2yr) · Bregal Milestone Fund I · 2018 · Growth
Bregal Milestone sold CUBE to Hg in 2024 after 2 years.
HgActive
2024 · present(2yr) · Hg Mercury 4 · 2023 · Buyout
More from Hg Mercury 4
Other portfolio companies in the same fund.
Germany
Belgium
SpainMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns CUBE?
CUBE is currently owned by Hg and ARCHIMED, through Hg Mercury 4, since 2024.
When did Hg and 1 other acquire CUBE?
Hg and 1 other acquired CUBE in 2024.
Who did CUBE sell to?
Bregal Milestone sold CUBE to Hg in 2024 (Trade Sale).
Who has owned CUBE over time?
CUBE has been through 3 private-equity ownership periods: ARCHIMED · via MED III · since 2021; Bregal Milestone · via Bregal Milestone Fund I · 2022–2024 · sold to Hg · (Trade Sale); Hg · via Hg Mercury 4 · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue